fbpx

The U.S. Just Signed A $450 Million Coronavirus Vaccine Contract With Johnson & Johnson

March 30, 2020 -- Forbes reports on the half billion dollar grant to J&J to create develop the COVID-19 vaccine.

That’s according to a $456 million order with Johnson & Johnson’s Pharmaceuticals arm Janssen, which specified a “new vaccine asset for 2019 Novel Coronavirus (COVID-19),” Forbes found. It’s the largest reported amount spent on a vaccine project to date, even though the pharma giant hasn’t yet started any clinical trials as other firms have.

Read the article on Forbes: The U.S. Just Signed A $450 Million Coronavirus Vaccine Contract With Johnson & Johnson

 

 

 

 Credo Watch asks the question: With more than 90,000 product liability claims, does Johnson & Johnson still deserve the reputation it earned in the mid-twentieth century? And does Johnson & Johnson still adhere to its famous Credo established in 1943?

All articles posted on CredoWatch.com are provided as public information, and they are free to be republished in part or in whole with or without attribution.